INTRODUCTION: Interleukins and cytokines play an important role in the pathogenesis of many cancers.We aimed to evaluate the interleukin (IL)-6 gene polymorphisms in patients with papillary thyroid carcinoma (PTC) and control subjects. MATERIAL AND METHODS: In this study, 42 patients with PTC and 340 healthy controls were included. Peripheral blood samples were taken from control group and patients, and blood samples were preserved at -80 C in tubes containing Na-EDTA. RESULTS: We also found a statistically significant difference between patients with PTC and the control group with respect to IL-6 genotype (p<0.05). IL-6 gene polymorphism in patients with PTC patients did not reveal statistically significant difference between the 2 groups (size of tumor >1 cm and <1 cm), multicentricity, RET-PTC types and capsule invasion (p>0.05).We also did not find a statistically significant difference between patients with PTC and the control group with respect to IL-6-gene allele frequency (p>0.05). DISCUSSION: Our data suggest that the IL-6 G-174 C polymorphism could play a role in thyroid cancer risk, but there is no effective role as a prognostic factor.
INTRODUCTION: Interleukins and cytokines play an important role in the pathogenesis of many cancers.We aimed to evaluate the interleukin (IL)-6 gene polymorphisms in patients with papillary thyroid carcinoma (PTC) and control subjects. MATERIAL AND METHODS: In this study, 42 patients with PTC and 340 healthy controls were included. Peripheral blood samples were taken from control group and patients, and blood samples were preserved at -80 C in tubes containing Na-EDTA. RESULTS: We also found a statistically significant difference between patients with PTC and the control group with respect to IL-6 genotype (p<0.05). IL-6 gene polymorphism in patients with PTC patients did not reveal statistically significant difference between the 2 groups (size of tumor >1 cm and <1 cm), multicentricity, RET-PTC types and capsule invasion (p>0.05).We also did not find a statistically significant difference between patients with PTC and the control group with respect to IL-6-gene allele frequency (p>0.05). DISCUSSION: Our data suggest that the IL-6G-174 C polymorphism could play a role in thyroid cancer risk, but there is no effective role as a prognostic factor.
Authors: R M Ruggeri; D Villari; A Simone; R Scarfi; M Attard; F Orlandi; G Barresi; F Trimarchi; M Trovato; S Benvenga Journal: J Endocrinol Invest Date: 2002-12 Impact factor: 4.256
Authors: Xeni Provatopoulou; Despoina Georgiadou; Theodoros N Sergentanis; Eleni Kalogera; John Spyridakis; Antonia Gounaris; George N Zografos Journal: Inflamm Res Date: 2014-05-03 Impact factor: 4.575
Authors: Young Gyu Eun; Il Ki Hong; Su Kang Kim; Hyun-Kyung Park; Sam Kwon; Dae Han Chung; Kee Hwan Kwon Journal: Clin Exp Otorhinolaryngol Date: 2011-09-06 Impact factor: 3.372
Authors: Toral P Kobawala; Trupti I Trivedi; Kinjal K Gajjar; Darshita H Patel; Girish H Patel; Nandita R Ghosh Journal: J Thyroid Res Date: 2016-03-13
Authors: Paula Boaventura; Cecília Durães; Adélia Mendes; Natália Rios Costa; Inês Chora; Sara Ferreira; Emanuel Araújo; Pedro Lopes; Gilberto Rosa; Pedro Marques; Paulo Bettencourt; Inês Oliveira; Francisco Costa; Isabel Ramos; Maria José Teles; João Tiago Guimarães; Manuel Sobrinho-Simões; Paula Soares Journal: PLoS One Date: 2016-09-23 Impact factor: 3.240